Semler Scientific Inc (OQ:SMLR)
Business Focus: Medical Equipment
Apr 23, 2024 08:03 am ET
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
SANTA CLARA, Calif., April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial markets on Tuesday, May 7, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, and Jennifer Oliva-Her
Feb 21, 2024 07:03 am ET
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
SANTA CLARA, Calif., Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023, after the close of U.S. financial markets on Tuesday, March 5, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, and
Nov 09, 2023 03:01 pm ET
Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
2023 Q3 highlights:
Oct 26, 2023 04:01 pm ET
Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
SANTA CLARA, Calif., Oct. 26, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2023, after the close of U.S. financial markets on Thursday, November 9, 2023. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial
Jul 28, 2023 08:03 am ET
Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
SANTA CLARA, Calif., July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the second quarter ended June 30, 2023, after the close of U.S. financial markets on Thursday, August 10, 2023. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, will join him on t
Jul 11, 2023 08:03 am ET
Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
SANTA CLARA, Calif., July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining.
Jun 23, 2023 04:01 pm ET
Semler Scientific to Join the Russell 2000® and 3000® Indexes
SANTA CLARA, Calif., June 23, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it is set to join the Russell 2000® and 3000® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023.
May 10, 2023 04:01 pm ET
Semler Scientific Reports First Quarter 2023 Financial Results
2023 Q1 highlights:
May 01, 2023 04:01 pm ET
Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
SANTA CLARA, Calif., May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2023, after the close of U.S. financial markets on Wednesday, May 10, 2023. Doug Murphy-Chutorian, M.D., interim chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, Dennis Rosenbe
Apr 28, 2023 04:01 pm ET
Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
SANTA CLARA, Calif., April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian, M.D., former CEO and a current member of the board of directors as chief executive officer (CEO) on an interim basis with immediate effect. The board intends to conduct a global search for a permanent CEO.
Apr 19, 2023 04:01 pm ET
Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors
Eric Semler Appointed as Chairman
Apr 05, 2023 08:03 am ET
Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif., April 5, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Wayne T. Pan, Ph.D., M.D., and head of corporate communications and business strategy, Renae Cormier, will present a company overview at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, at 4:30 pm ET. Management will also participate in one-on-one calls with investors on Tuesday, April 18.
Apr 03, 2023 08:01 am ET
Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement
SANTA CLARA, Calif., April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, commented on the recent Centers for Medicare and Medicaid Services (CMS) 2024 Medicare Advantage and Part D Final Rate Announcement.
Mar 21, 2023 04:05 pm ET
Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results
2022 Q4 and Full Year highlights compared to the corresponding period of 2021:
Mar 21, 2023 04:01 pm ET
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023
SANTA CLARA, Calif., March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian, M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition period. He will continue to serve as a member of the board of directors at least through the remainder of his 2024 term.
Dec 14, 2022 07:03 am ET
Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
SANTA CLARA, Calif., Dec. 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home screening. AJPM Focus is the official open access journal jointly launched this year by both The American College of Preventive Medicine and the Association for Prevention Teachin
Dec 12, 2022 07:05 am ET
Semler Announces Investment in Monarch Medical Technologies
SANTA CLARA, Calif., Dec. 12, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of a senior secured convertible promissory note. Repayment of the note is secured by a first priority interest in all of Monarch's assets.
Nov 01, 2022 04:01 pm ET
Semler Reports Third Quarter and Year-to-Date 2022 Financial Results
2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021:
Oct 19, 2022 04:01 pm ET
Semler to Report Third Quarter and First Nine Months of 2022 Financial Results and Host Conference Call on November 1, 2022
SANTA CLARA, Calif., Oct. 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2022, after the close of U.S. financial markets on Tuesday, November 1, 2022. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and acco
Aug 31, 2022 08:03 am ET
Semler Scientific to Present at Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 31, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced, Head of Corporate Communications and Business Strategy, Renae Cormier, will participate in the following investor conferences:
Aug 02, 2022 04:01 pm ET
Semler Reports Second Quarter and First Half of 2022 Financial Results
2022 Q2 quarterly HIGHLIGHTS compared to the corresponding period of 2021:
Jul 21, 2022 08:03 am ET
Semler to Report Second Quarter and First Half 2022 Financial Results and Host Conference Call on August 2, 2022
SANTA CLARA, Calif., July 21, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first half ended June 30, 2022, after the close of U.S. financial markets on Tuesday, August 2, 2022. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, Denni
May 02, 2022 04:01 pm ET
Semler Reports First Quarter 2022 Financial Results
2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021:
Apr 19, 2022 08:03 am ET
Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2, 2022
SANTA CLARA, Calif., April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2022, after the close of U.S. financial markets on Monday, May 2, 2022. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and Dennis Rosenberg,
Apr 07, 2022 08:03 am ET
Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif., April 7, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, at 1:30 pm ET. Management will also participate in one-on-one calls with investors.
Mar 14, 2022 04:01 pm ET
Semler Scientific's Board of Directors authorizes an up to $20.0 million stock repurchase program
SANTA CLARA, Calif., March 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its board of directors has authorized a $20.0 million stock repurchase program.
Mar 01, 2022 07:01 am ET
Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery
SANTA CLARA, Calif., March 1, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced a study was published on-line as a pre-proof in the peer-reviewed Journal of Vascular Surgery with data collected using QuantaFlo® under real-world conditions.
Feb 28, 2022 03:01 pm ET
Semler Reports Fourth Quarter and Year-to-Date 2021 Financial Results
SANTA CLARA, Calif., Feb. 28, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months and year ended December 31, 2021.
Feb 17, 2022 07:03 am ET
Semler to Report Fourth Quarter and Year End 2021 Financial Results and Host Conference Call on February 28, 2022
SANTA CLARA, Calif., Feb. 17, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2021, after the close of U.S. financial markets on Monday, February 28, 2022. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting,
Nov 01, 2021 04:01 pm ET
Semler Reports Third Quarter and Year-to-Date 2021 Financial Results
SANTA CLARA, Calif., Nov. 1, 2021 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2021.
Oct 22, 2021 08:03 am ET
Semler to Report Third Quarter and First Nine Months of 2021 Financial Results and Host Conference Call on November 1, 2021
SANTA CLARA, Calif., Oct. 22, 2021 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2021, after the close of U.S. financial markets on Monday, November 1, 2021. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and acco
Sep 27, 2021 08:03 am ET
Semler Scientific to Commence Trading on Nasdaq
SANTA CLARA, Calif., Sept. 27, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that The Nasdaq Stock Market LLC ("Nasdaq") has approved the listing of its common stock on the exchange. Semler Scientific's common stock will begin trading on The Nasdaq Capital Market under the trading symbol "SMLR" at the open of the market on Tuesday, September 28, 2021. Semler Scientific's common stock will continue to trade on the OTCQB until market close on
Aug 26, 2021 08:03 am ET
Semler Scientific to Present at Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that Chief Executive Officer Doug Murphy-Chutorian, M.D. and Chief Marketing Officer Dennis Rosenberg will participate in the following investor conferences that are being held virtually in September.
Aug 02, 2021 04:01 pm ET
Semler Reports Second Quarter and First Half of 2021 Financial Results
SANTA CLARA, Calif., Aug. 2, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2021.
Jul 21, 2021 08:03 am ET
Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021
SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first half ended June 30, 2021, after the close of U.S. financial markets on Monday, August 2, 2021. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and Den
Jun 10, 2021 08:03 am ET
Semler to Participate in the Raymond James Human Health Innovation Conference
SANTA CLARA, Calif., June 10, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the Raymond James Human Health Innovation Conference on Tuesday, June 22, at 12:00 pm ET.
Feb 25, 2021 07:03 am ET
Semler to Participate in the H.C. Wainwright Global Life Sciences Conference
SANTA CLARA, Calif., Feb. 25, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the H.C. Wainwright Global Life Sciences Conference.
Feb 22, 2021 07:03 am ET
Semler to Report Fourth Quarter and Year End 2020 Financial Results and Host Conference Call on March 1, 2021
SANTA CLARA, Calif., Feb. 22, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2020 after the close of U.S. financial markets on Monday, March 1, 2021. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and D
Jan 07, 2021 07:03 am ET
Semler to Participate in the H.C. Wainwright BioConnect 2021 Conference
SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the H.C. Wainwright BioConnect 2021 Conference.
Nov 12, 2020 07:03 am ET
Semler Scientific Expands Board of Directors with Appointment of Policy Expert Cindy Moon
SANTA CLARA, Calif., Nov. 12, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Cindy Moon, a D.C.-based, healthcare payment policy expert, to its Board of Directors, effective November 10, 2020. With this addition, Semler's Board now totals five members.
Nov 05, 2020 07:03 am ET
Semler Reports Record Third Quarter and Year-to-Date 2020 Financial Results
SANTA CLARA, Calif., Nov. 5, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2020.
Oct 22, 2020 08:03 am ET
Semler to Report Third Quarter and First Nine Months of 2020 Financial Results and Host Conference Call on November 5, 2020
SAN JOSE, Calif., Oct. 22, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 3:00 p.m. ET the same day.
Aug 03, 2020 04:01 pm ET
Semler Reports Second Quarter and First Half 2020 Financial Results
SAN JOSE, Calif., Aug. 3, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2020.
Jul 27, 2020 08:03 am ET
Semler to Report Second Quarter and First Half 2020 Financial Results and Host Conference Call on August 3, 2020
SAN JOSE, Calif., July 27, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first half ended June 30, 2020 after the close of U.S. financial markets on Monday, August 3, 2020. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and Dennis
May 04, 2020 04:01 pm ET
Semler Reports First Quarter 2020 Financial Results
SAN JOSE, Calif., May 4, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months ended March 31, 2020.
Apr 21, 2020 08:03 am ET
Semler to Report First Quarter 2020 Financial Results and Host Conference Call on May 4, 2020
SAN JOSE, Calif., April 21, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2020 after the close of U.S. financial markets on Monday, May 4, 2020. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and Dennis Rosenberg, chief
Oct 30, 2019 04:01 pm ET
Semler Reports Record Third Quarter and Year-to-Date 2019 Financial Results
SAN JOSE, Calif., Oct. 30, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2019.
Oct 23, 2019 04:05 pm ET
Semler to Report Third Quarter and First Nine Months of 2019 Financial Results and Host Conference Call on October 30, 2019
SAN JOSE, Calif., Oct. 23, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third quarter ended September 30, 2019 at the close of U.S. financial markets on Wednesday, October 30, 2019. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 p.m. ET the same day.
Jul 26, 2019 08:03 am ET
Semler Reports Record Second Quarter and First Half 2019 Financial Results
SAN JOSE, Calif., July 26, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2019.
Jul 16, 2019 08:33 am ET
Semler to Report Second Quarter and First Half 2019 Financial Results on July 26, 2019
SAN JOSE, Calif., July 16, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first half ended June 30, 2019 before the open of U.S. financial markets on Friday, July 26, 2019.
Apr 29, 2019 04:01 pm ET
Semler Reports First Quarter 2019 Financial Results
SAN JOSE, Calif., April 29, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months ended March 31, 2019.
Apr 18, 2019 08:03 am ET
Semler to Report First Quarter 2019 Financial Results and Host Conference Call on April 29, 2019
SAN JOSE, Calif., April 18, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2019 at the close of U.S. financial markets on Monday, April 29, 2019. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 p.m. ET the same day.
Feb 27, 2019 07:03 am ET
Semler Reports Fourth Quarter and Year End 2018 Financial Results
SAN JOSE, Calif., Feb. 27, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months and year ended December 31, 2018.
Feb 14, 2019 07:03 am ET
Semler to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call on February 27, 2019
SAN JOSE, Calif., Feb. 14, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for fourth quarter and full year ended December 31, 2018 before the open of U.S. financial markets on Wednesday, February 27, 2019. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
Oct 26, 2018 08:03 am ET
Semler Reports Third Quarter and Year-to-Date 2018 Financial Results
SAN JOSE, Calif., Oct. 26, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2018.
Oct 16, 2018 08:03 am ET
Semler to Report Third Quarter and First Nine Months of 2018 Financial Results and Host Conference Call on October 26, 2018
SAN JOSE, Calif., Oct. 16, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for third quarter and nine months ended September 30, 2018 before the open of U.S. financial markets on Friday, October 26, 2018. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
Jul 31, 2018 08:03 am ET
Semler Reports Second Quarter and First Half 2018 Financial Results
SAN JOSE, Calif., July 31, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2018.
Jul 23, 2018 08:03 am ET
Semler to Report Second Quarter and First Half 2018 Financial Results and Host Conference Call on July 31, 2018
SAN JOSE, Calif., July 23, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report second quarter and first half 2018 financial results before the open of U.S. financial markets on Tuesday, July 31, 2018. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
May 01, 2018 08:03 am ET
Semler Reports First Quarter 2018 Financial Results
SAN JOSE, Calif., May 1, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months ended March 31, 2018.
Apr 19, 2018 08:03 am ET
Semler to Report First Quarter 2018 Financial Results and Host Conference Call on May 1, 2018
SAN JOSE, Calif., April 19, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report first quarter 2018 financial results before the open of U.S. financial markets on Tuesday, May 1, 2018. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
Feb 28, 2018 08:40 am ET
Semler Scientific, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Semler Scientific, Inc. (OTCQB: SMLR) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018 at 11:00 AM Eastern Time.
Feb 28, 2018 07:03 am ET
Semler Reports Fourth Quarter and Yearly 2017 Financial Results
SAN JOSE, Calif., Feb. 28, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the fourth quarter and year ended December 31, 2017.
Feb 15, 2018 07:03 am ET
Semler to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 28, 2018
SAN JOSE, Calif., Feb. 15, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report fourth quarter and full year 2017 financial results before the open of U.S. financial markets on Wednesday, February 28, 2018. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
Oct 31, 2017 09:03 am ET
Semler Reports Third Quarter and Year-to-Date 2017 Financial Results
PORTLAND, Ore., Oct. 31, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the third quarter and year-to-date ended September 30, 2017.
Oct 19, 2017 09:03 am ET
Semler to Report Third Quarter 2017 Financial Results and Host Conference Call on October 31, 2017
PORTLAND, Ore., Oct. 19, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report third quarter 2017 financial results before the open of U.S. financial markets on Tuesday, October 31, 2017. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
Aug 02, 2017 09:03 am ET
Semler Reports Second Quarter and First Half 2017 Financial Results
PORTLAND, Ore., Aug. 2, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the second quarter and six months ended June 30, 2017.
Jul 24, 2017 09:03 am ET
Semler to Report Second Quarter 2017 Financial Results and Host Conference Call on August 2, 2017
PORTLAND, Ore., July 24, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report second quarter 2017 financial results before the open of U.S. financial markets on Wednesday, August 2, 2017. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
May 09, 2017 09:03 am ET
Semler Reports First Quarter 2017 Financial Results
PORTLAND, Ore., May 9, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the first quarter ended March 31, 2017.
Apr 18, 2017 09:03 am ET
Semler to Report First Quarter 2017 Financial Results and Host Conference Call on May 9, 2017
PORTLAND, Ore., April 18, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness of healthcare providers, today announced that it will report first quarter 2017 financial results before the open of U.S. financial markets on May 9, 2017. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day.
Mar 10, 2017 08:03 am ET
Semler Reports Fourth Quarter and Annual 2016 Financial Results
PORTLAND, Ore., March 10, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness of healthcare providers, today reported financial results for the fourth quarter and year ended December 31, 2016.
Feb 16, 2017 08:03 am ET
Semler to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on March 10, 2017
PORTLAND, Ore., Feb. 16, 2017 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness of healthcare providers, today announced that it will report fourth quarter and full year 2016 financial results before the open of U.S. financial markets on March 10, 2017. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Nov 21, 2016 07:05 am ET
Semler Scientific Recognized By Deloitte's Technology Fast 500™ Growth Award
PORTLAND, Ore., Nov. 21, 2016 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups, today announced it ranked No. 176 on Deloitte's Technology Fast 500™, a ranking of the 500 fastest growing technology, life sciences and energy tech companies in North America (United States and Canada). This ranking made Semler the 9th fastest growing company in the Medical Device category according to Deloitte. This year's Technology Fast 500™ award w
Oct 28, 2016 09:03 am ET
Semler Reports Third Quarter and Year-to-Date 2016 Financial Results
PORTLAND, Ore., Oct. 28, 2016 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups, today reported financial results for the third quarter and year-to-date ended September 30, 2016.
Oct 19, 2016 08:37 am ET
Semler to Report Third Quarter 2016 Financial Results and Host Conference Call on October 28, 2016
PORTLAND, Ore., Oct. 19, 2016 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups, today announced that it will report third quarter 2016 financial results before the open of U.S. financial markets on October 28, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Aug 11, 2016 05:18 pm ET
Semler Scientific, Inc. To Begin Trading on OTCQB®
PORTLAND, Ore., Aug. 11, 2016 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR; "Semler"), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, announced today that its common stock will be delisted from the NASDAQ Capital Market and that suspension of trading in the shares was effective at the open of business on August 11, 2016 for failure to regain compliance with the required $2,500,000 minimum stockholders' equity for continued listing within the compliance periods afforded by
Jul 29, 2016 09:03 am ET
Semler Reports Second Quarter and Year-to-date 2016 Financial Results
PORTLAND, Ore., July 29, 2016 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the second quarter and year-to-date ended June 30, 2016.
Jul 21, 2016 09:03 am ET
Semler to Report Second Quarter 2016 Financial Results and Host Conference Call on July 29, 2016
PORTLAND, Ore., July 21, 2016 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report second quarter 2016 financial results before the open of U.S. financial markets on July 29, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Apr 29, 2016 09:03 am ET
Semler Reports 2016 First Quarter Financial Results
PORTLAND, Ore., April 29, 2016 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the first quarter ended March 31, 2016.
Apr 20, 2016 09:03 am ET
Semler to Report First Quarter 2016 Financial Results and Host Conference Call on April 29, 2016
PORTLAND, Ore., April 20, 2016 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report first quarter 2016 financial results before the open of U.S. financial markets on April 29, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Feb 19, 2016 08:03 am ET
Semler Reports 2015 Annual and Fourth Quarter Financial Results
PORTLAND, Ore., Feb. 19, 2016 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the fourth quarter and year ended December 31, 2015.
Feb 09, 2016 08:03 am ET
Semler to Report Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on February 19, 2016
PORTLAND, Ore., Feb. 9, 2016 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report fourth quarter and full year 2015 financial results before the open of U.S. financial markets on February 19, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.